| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/20/2006 | CA2594911A1 Peptides for delivery of mucosal vaccines |
| 07/20/2006 | CA2594533A1 Method of treating staphylococcus aureus infection |
| 07/20/2006 | CA2594318A1 Irta-2 antibodies and their uses |
| 07/20/2006 | CA2593786A1 Kid31 and antibodies that bind thereto |
| 07/20/2006 | CA2593779A1 Li-key/antigenic epitope hybrid peptide vaccines |
| 07/20/2006 | CA2593777A1 Anti-.alpha.9 integrin antibody and the use thereof |
| 07/20/2006 | CA2593574A1 Combination cancer therapy with anti-psma antibodies |
| 07/20/2006 | CA2592444A1 Adhesin as immunogen against escherichia coli |
| 07/20/2006 | CA2590163A1 Treatment method |
| 07/20/2006 | CA2587321A1 Improved prrs vaccines |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1681350A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681301A1 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
| 07/19/2006 | EP1681300A1 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS |
| 07/19/2006 | EP1681064A1 Induction of antigen-specific T cells by interferon |
| 07/19/2006 | EP1680499A2 Modulation of angiogenesis by bartonella henselae |
| 07/19/2006 | EP1680446A2 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
| 07/19/2006 | EP1680445A1 Polyvalent allergy vaccine |
| 07/19/2006 | EP1680444A1 New soluble and stabilized trimeric form of gp41 polypeptides |
| 07/19/2006 | EP1680178A2 System and method for transdermal vaccine delivery |
| 07/19/2006 | EP1680140A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 07/19/2006 | EP1680080A2 Neutrophil activation by immune response modifier compounds |
| 07/19/2006 | EP1680009A2 Compositions and methods for diagnosing and treating mental disorders |
| 07/19/2006 | EP1395273B1 Targeted delivery of drugs for the treatment of viral infections |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1255815B1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 07/19/2006 | EP1140107B1 Agonists and antagonists of peripheral-type benzodiazepine receptors |
| 07/19/2006 | EP1082967B1 Prevention and treatment of autoimmune demyelinating diseases by Fas-antagonists |
| 07/19/2006 | EP1076566B1 Attenuated mutants of salmonella which constitutively express the vi antigen |
| 07/19/2006 | EP0690724B1 Chlamydia vaccine comrising anti-idiotypic antibodies |
| 07/19/2006 | CN1806172A Method for selecting and producing vaccine components and vaccines based thereon |
| 07/19/2006 | CN1805769A CNS chloride modulation and uses thereof |
| 07/19/2006 | CN1805758A Nucleotide and cellular vaccine composition |
| 07/19/2006 | CN1805757A Recombinant antibodies, and compositions and methods for making and using the same |
| 07/19/2006 | CN1805756A Vav inhibition in graft rejection. |
| 07/19/2006 | CN1805755A Therapeutic use of anti- CS1 antibodies |
| 07/19/2006 | CN1805754A Functionally reconstituted viral membranes containing adjuvant |
| 07/19/2006 | CN1804041A Human decorin-expressing recombined adeno-associated virus and preparation method thereof |
| 07/19/2006 | CN1804039A Virulence genes, proteins, and their use |
| 07/19/2006 | CN1804037A Expression method of glucosal related protein and application thereof |
| 07/19/2006 | CN1803842A Antibody for treating or preventing senile dementia, its expression vector and application in drug preparation |
| 07/19/2006 | CN1803841A Single chain antibody of HIV1//2 antigen and quick detection reagent thereof |
| 07/19/2006 | CN1803195A Immunity regulating type Eimeria tenella DNA vaccine for preventing and treating chicken coccidiosis |
| 07/19/2006 | CN1803194A Immunity regulating type DNA vaccine for preventing and treating chicken coccidiosis |
| 07/19/2006 | CN1803190A Immune and antiallergic oral product containing IgY and potassium salt, strontium salt added composition, and its preparation method |
| 07/19/2006 | CN1264980C Novel tumor antigen protein SART-3 and tumor antigen peptide thereof |
| 07/19/2006 | CN1264975C Recopulated strain of rotavirus gene |
| 07/19/2006 | CN1264862C Diphtherin-gonadoliberin chimeric protein |
| 07/19/2006 | CN1264859C Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof |
| 07/19/2006 | CN1264857C Recombinant fusion protein (vaccine), composition containing the same and method for prodution thereof |
| 07/19/2006 | CN1264856C Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/19/2006 | CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound |
| 07/19/2006 | CN1264573C Method for preparing targeting preparation of human monoclonal antibody crosslinking interferon for anti hepatitis b virus |
| 07/19/2006 | CN1264572C Fusion protein for treating HBV and its uses |
| 07/19/2006 | CN1264571C Composite inactivated vaccin for rainbow virus or streptococcus infection and complication thereof of fishes |
| 07/19/2006 | CN1264568C Virulence genes and proteins, and their use |
| 07/18/2006 | US7078516 Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078513 plasmid is a viral or bacterial expression vector and is expressed in a prokaryotic or eukaryotic cell; gene therapy and immunotherapy; prenatal screening and diagnosis |
| 07/18/2006 | US7078512 Encoding feline CD-86, -80, -28 and -152 receptors and ligands; enhancing and suppressing immune response in felines |
| 07/18/2006 | US7078508 Anticoagulant; Dna immobilized on substrate; binding to antibody |
| 07/18/2006 | US7078507 Synthetic genes for malarial proteins and methods of use |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078492 Human antipneumococcal antibodies from non-human animals |
| 07/18/2006 | US7078483 Retroviral vectors including modified envelope escort proteins |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078388 DNA vaccines for farm animals, in particular bovines and porcines |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078205 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia and alzheimer's diseases |
| 07/18/2006 | US7078193 Pathogenic Escherichia coli associated protein espA |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078044 Antiinflammatory agents; antiarthritic agents; antiscarring agents; isolated oligopeptide |
| 07/18/2006 | US7078043 Malaria vaccine |
| 07/18/2006 | US7078042 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 07/18/2006 | US7078041 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 07/18/2006 | US7078039 vaccine; inducing immunology response; peptide |
| 07/18/2006 | US7078038 Gp120 mutants and biological applications |
| 07/18/2006 | US7078037 Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections |
| 07/18/2006 | US7078036 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 07/18/2006 | US7078028 Anti-neoplastic viral agents |
| 07/18/2006 | US7078024 Compositions and method for promoting the growth of human hair |
| 07/18/2006 | US7078013 Pretargeting methods and compounds |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/13/2006 | WO2006074418A2 Ovr110 antibody compositions and methods of use |
| 07/13/2006 | WO2006074303A2 Delivery vehicles, bioactive substances and viral vaccines |
| 07/13/2006 | WO2006074228A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 07/13/2006 | WO2006074199A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/13/2006 | WO2006074187A2 Method of treating brain cancer |
| 07/13/2006 | WO2006074179A2 Blockade of elr+cxc chemokines as a treatment for inflammatory and autoimmune disease |
| 07/13/2006 | WO2006073982A2 Bispecific molecule comprising ligands for cell-surface protein and t-cell surface protein |
| 07/13/2006 | WO2006073827A2 Neutralizing epitope-based growth enhancing vaccine |
| 07/13/2006 | WO2006073748A2 Antibodies against antigen presenting cells and uses thereof |
| 07/13/2006 | WO2006073627A2 Vaccinia virus nucleic acids, polypeptides, and immunogenic compositions |
| 07/13/2006 | WO2006073493A2 Vaccine conjugates comprising a monoclonal antibody binding to human dentritic cells and beta human chronic gonadotropin |
| 07/13/2006 | WO2006073443A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use |